Skip to main content
. 2021 Jul 20;19:220. doi: 10.1186/s12957-021-02305-3

Table 1.

Demographic characteristics of patients

All patients (n=67) Patients who underwent surgery in our center (n=54)
Variables Value, N (%) Variables Value, N (%)
Age (year) HIPEC
 ≥60 49 (73.1%)  No 32 (59.3%)
 <60 18 (26.9%)  Yes 22 (40.7%)
Primary cancer Tumor deposits
 Left colon cancer 41 (61.2%)  None 29 (53.7%)
 Right colon cancer 24 (35.8%)  Present 10 (18.5%)
 Unknown 2 (3.0%)  Unknown 5 (9.3%)
Pathological type Primary tumor size
 Adenocarcinoma 51 (76.1%)  <5cm 29 (53.7%)
 Non-adenocarcinoma 16 (23.9%)  ≥5cm 14 (35.9%)
 Unknown 11 (20.4%)
Grade Perineural invasion
 Grade I 6 (9.0%)  None 17 (31.5%)
 Grade II 40 (59.7%)  Present 30 (55.6%)
 Grade III 18 (26.9%)  Unknown 7 (13.0%)
 Unknown 3 (4.5%)
T stage Scope Reg LN Sur
 T0-3 14 (20.9%)  None 13 (24.1%)
 T4 44 (65.7%)  Present 36 (66.7%)
 Tx 9 (13.4%)  Unknown 5 (9.3%)
N stage Scope Reg LN Sur (Number)
 N0 15 (22.4%)  <4 32 (59.3%)
 N1 23(34.3%)  ≥4 17 (31.5% (%))
 N2 19 (28.4%)  Unknown 5 (9.3%)
 Nx 10 (14.9%)
Primary tumor size Metastatic tumor size
 <5cm 30 (44.8%)  ≤15cm 37 (68.5%)
 ≥5cm 15 (22.4%)  >15cm 14 (25.9%)
 Unknown 22 (32.8%)  Unknown 3 (5.6%)
Time of OM Time of OM
 Synchronous 36 (53.7%)  Synchronous 31 (57.4%)
 Metachronous 31 (46.3%)  Metachronous 23 (42.6%)
Number of OM
 Unilateral 21 (38.9%)
 Bilateral 31 (57.4%)
 Unknown 2 (3.7%)
Parenchymatous organ metastasis
 None 18 (33.3%)
 OM+PM 14 (25.9%)
 OM+PM+others 17 (31.5%)
 OM+others 5 (9.3%)
Peritoneal metastasis
 No 32 (59.3%)
 Yes 22 (40.7%)
CA125
 ≤ 40 kU/L 20 (37.0%)
 >40 kU/L 25 (46.3%)
 Unknown 9 (16.7%)
CEA
 ≤30 mg/L 32 (59.3%)
 >30 mg/L 15 (27.8%)
 Unknown 7 (13.0%)
CA199
 ≤60 kU/L 31 (57.4%)
 >60 kU/L 16 (29.6%)
 Unknown 7 (13.0%)
PCI
≤10 29 (53.7%)
>10 25 (46.3%)
CC
 0–1 37 (68.5%)
 >1 17 (31.5%)